Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100608643 | 10060864 | 3 | F | 201404 | 20140922 | 20140404 | 20140930 | EXP | US-ABBVIE-14P-163-1218431-00 | ABBVIE | 76.03 | YR | M | Y | 0.00000 | 20140930 | N | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100608643 | 10060864 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | SUBCUTANEOUS | D | 1011075 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | |||||
| 100608643 | 10060864 | 2 | C | ACEBUTOLOL | ACEBUTOLOL | 1 | D | 0 | TABLET | ||||||||||
| 100608643 | 10060864 | 3 | C | WARFARIN | WARFARIN | 1 | MON, WED, FRID AND SUN | D | 0 | TABLET | |||||||||
| 100608643 | 10060864 | 4 | C | POTASSIUM | POTASSIUM | 1 | D | 0 | QD | ||||||||||
| 100608643 | 10060864 | 5 | C | TORSEMIDE. | TORSEMIDE | 1 | D | 0 | 20 | MG | QD | ||||||||
| 100608643 | 10060864 | 6 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | D | 0 | TABLET | QD | |||||||||
| 100608643 | 10060864 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | D | 0 | TABLET | QD | |||||||||
| 100608643 | 10060864 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | D | 0 | 1 | MG | TABLET | QD | |||||||
| 100608643 | 10060864 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | D | 0 | 2 | DF | QD | ||||||||
| 100608643 | 10060864 | 10 | C | IRON | IRON | 1 | D | 0 | TABLET | QD | |||||||||
| 100608643 | 10060864 | 11 | C | PREDNISONE. | PREDNISONE | 1 | D | 0 | 7 | MG | QD | ||||||||
| 100608643 | 10060864 | 12 | C | METHOTREXATE | METHOTREXATE | 1 | ON WED | D | 0 | 15 | MG | /wk | |||||||
| 100608643 | 10060864 | 13 | C | VITAMIN D | CHOLECALCIFEROL | 1 | D | 0 | 2000 | IU | QD | ||||||||
| 100608643 | 10060864 | 14 | C | SULFASALAZINE. | SULFASALAZINE | 1 | 6 PILLS | D | 0 | TABLET | QD | ||||||||
| 100608643 | 10060864 | 15 | C | GABAPENTIN. | GABAPENTIN | 1 | D | 0 | 3 | DF | TABLET | BID | |||||||
| 100608643 | 10060864 | 16 | C | HYDROCODONE | HYDROCODONE | 1 | 10/325 MG, USUALLY TWICE DAILY | D | 0 | ||||||||||
| 100608643 | 10060864 | 17 | C | MORPHINE | MORPHINE | 1 | ER TABLETS | D | 0 | 30 | MG | BID | |||||||
| 100608643 | 10060864 | 18 | C | LISINOPRIL. | LISINOPRIL | 1 | D | 0 | TABLET | QD | |||||||||
| 100608643 | 10060864 | 19 | C | BIOLOGIC | 2 | D | 0 | ||||||||||||
| 100608643 | 10060864 | 20 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | D | 0 | 200 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100608643 | 10060864 | 1 | Rheumatoid arthritis |
| 100608643 | 10060864 | 2 | Arrhythmia |
| 100608643 | 10060864 | 3 | Arrhythmia |
| 100608643 | 10060864 | 4 | Product used for unknown indication |
| 100608643 | 10060864 | 5 | Hypertension |
| 100608643 | 10060864 | 6 | Depression |
| 100608643 | 10060864 | 7 | Blood triglycerides increased |
| 100608643 | 10060864 | 8 | Rheumatoid arthritis |
| 100608643 | 10060864 | 9 | Gastrooesophageal reflux disease |
| 100608643 | 10060864 | 10 | Product used for unknown indication |
| 100608643 | 10060864 | 11 | Rheumatoid arthritis |
| 100608643 | 10060864 | 12 | Rheumatoid arthritis |
| 100608643 | 10060864 | 13 | Product used for unknown indication |
| 100608643 | 10060864 | 14 | Rheumatoid arthritis |
| 100608643 | 10060864 | 15 | Product used for unknown indication |
| 100608643 | 10060864 | 16 | Pain |
| 100608643 | 10060864 | 17 | Pain |
| 100608643 | 10060864 | 18 | Hypertension |
| 100608643 | 10060864 | 19 | Product used for unknown indication |
| 100608643 | 10060864 | 20 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100608643 | 10060864 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100608643 | 10060864 | Abasia | |
| 100608643 | 10060864 | Chills | |
| 100608643 | 10060864 | Cognitive disorder | |
| 100608643 | 10060864 | Convulsion | |
| 100608643 | 10060864 | Drug effect delayed | |
| 100608643 | 10060864 | Drug ineffective | |
| 100608643 | 10060864 | Drug intolerance | |
| 100608643 | 10060864 | Dysarthria | |
| 100608643 | 10060864 | Dyspnoea | |
| 100608643 | 10060864 | Fatigue | |
| 100608643 | 10060864 | Feeling abnormal | |
| 100608643 | 10060864 | Hypotension | |
| 100608643 | 10060864 | Malaise | |
| 100608643 | 10060864 | Motor dysfunction | |
| 100608643 | 10060864 | Pain | |
| 100608643 | 10060864 | Pyrexia | |
| 100608643 | 10060864 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100608643 | 10060864 | 1 | 201402 | 201404 | 0 | |
| 100608643 | 10060864 | 18 | 20140307 | 0 |